← Back to All US Stocks

NEOG Stock Analysis 2026 - NEOGEN CORP AI Rating

NEOG Nasdaq In Vitro & In Vivo Diagnostic Substances MI CIK: 0000711377
Recently Updated • Analysis: Apr 13, 2026 • SEC Data: 2026-02-28
SELL
87% Conf
Pending
Analysis scheduled

📊 NEOG Key Takeaways

Revenue: $645.1M
Net Margin: 0.5%
Free Cash Flow: $5.7M
Current Ratio: 3.92x
Debt/Equity: 0.38x
EPS: $0.02
AI Rating: SELL with 87% confidence

Is NEOG a Good Investment? Thesis Analysis

Claude

Neogen faces fundamental operational challenges with zero revenue growth, negative operating income of -$24.7M, and the inability to cover interest expense from operations (interest coverage of -0.6x). Despite adequate liquidity and a strong gross margin, the company's razor-thin net margin (0.5%), minimal free cash flow ($5.7M), and massive EPS decline (-12,475% YoY) indicate deteriorating financial health with an unsustainable debt burden.

Why Buy NEOG? Key Strengths

Claude
  • + Strong gross margin of 46.6% indicates viable core product economics
  • + Excellent liquidity position with 3.92x current ratio and $159.9M cash
  • + Positive operating cash flow of $53.0M despite operating losses

NEOG Investment Risks to Consider

Claude
  • ! Negative operating income and inability to cover interest expense (interest coverage -0.6x) indicates unsustainable debt service
  • ! Zero revenue growth with stagnant business and minimal profitability ($3.4M net income on $645M revenue)
  • ! Extremely thin free cash flow margin (0.9%) leaves minimal financial flexibility for investments or economic downturns
  • ! Massive EPS decline of -12,475% YoY signals severe operational deterioration

Key Metrics to Watch

Claude
  • * Operating income trajectory and return to profitability
  • * Revenue growth acceleration and gross margin sustainability
  • * Interest coverage ratio stabilization and debt reduction progress
  • * Free cash flow generation and working capital efficiency

NEOG Financial Metrics

Revenue
$645.1M
Net Income
$3.4M
EPS (Diluted)
$0.02
Free Cash Flow
$5.7M
Total Assets
$3.4B
Cash Position
$159.9M

💡 AI Analyst Insight

The relatively thin 0.9% FCF margin may limit capital allocation flexibility. Strong liquidity with a 3.92x current ratio provides a solid financial cushion.

NEOG Profitability Ratios

Gross Margin 46.6%
Operating Margin -3.8%
Net Margin 0.5%
ROE 0.2%
ROA 0.1%
FCF Margin 0.9%

NEOG vs Default Sector

How NEOGEN CORP compares to Default sector averages

Net Margin
NEOG 0.5%
vs
Sector Avg 12.0%
NEOG Sector
ROE
NEOG 0.2%
vs
Sector Avg 15.0%
NEOG Sector
Current Ratio
NEOG 3.9x
vs
Sector Avg 1.8x
NEOG Sector
Debt/Equity
NEOG 0.4x
vs
Sector Avg 0.7x
NEOG Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is NEOG Overvalued or Undervalued?

Based on fundamental analysis, NEOGEN CORP has mixed fundamental signals relative to the Default sector in 2026.

Return on Equity
0.2%
Sector avg: 15%
Net Profit Margin
0.5%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.38x
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

NEOG Balance Sheet & Liquidity

Current Ratio
3.92x
Quick Ratio
2.84x
Debt/Equity
0.38x
Debt/Assets
37.4%
Interest Coverage
-0.65x
Long-term Debt
$793.3M

NEOG 5-Year Financial Trend & Growth Analysis

NEOG 5-year financial data: Year 2021: Revenue $468.5M, Net Income $60.2M, EPS $0.57. Year 2022: Revenue $527.2M, Net Income $59.5M, EPS $0.56. Year 2023: Revenue $822.4M, Net Income $60.9M, EPS $0.57. Year 2024: Revenue $924.2M, Net Income $48.3M, EPS $0.45. Year 2025: Revenue $924.2M, Net Income -$22.9M, EPS $-0.12.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: NEOGEN CORP's revenue has grown significantly by 97% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.12 indicates the company is currently unprofitable.

NEOG Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
0.9%
Free cash flow / Revenue

NEOG Quarterly Performance

Quarterly financial performance data for NEOGEN CORP including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2026 $211.2M $3.4M $0.02
Q2 2026 $224.7M -$15.9M $-0.07
Q1 2026 $209.2M -$12.6M $-0.06
Q3 2025 $221.0M -$2.0M $-0.01
Q2 2025 $229.6M -$2.0M $-0.01
Q3 2024 $218.3M -$2.0M $-0.01
Q2 2024 $229.6M -$2.0M $-0.01
Q1 2024 $132.3M $1.5M $0.01

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

NEOG Capital Allocation

Operating Cash Flow
$53.0M
Cash generated from operations
Stock Buybacks
$3.1M
Shares repurchased (TTM)
Capital Expenditures
$47.3M
Investment in assets
Dividends
None
No dividend program

NEOG SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for NEOGEN CORP (CIK: 0000711377)

📋 Recent SEC Filings

Date Form Document Action
Apr 9, 2026 10-Q neog-20260228.htm View →
Apr 9, 2026 8-K neog-20260409.htm View →
Mar 30, 2026 8-K neog-20260330.htm View →
Feb 17, 2026 4 xslF345X05/primary_doc.xml View →
Feb 2, 2026 4 xslF345X05/primary_doc.xml View →

Frequently Asked Questions about NEOG

What is the AI rating for NEOG?

NEOGEN CORP (NEOG) has an AI rating of SELL with 87% confidence, based on fundamental analysis of SEC EDGAR filings.

What are NEOG's key strengths?

Claude: Strong gross margin of 46.6% indicates viable core product economics. Excellent liquidity position with 3.92x current ratio and $159.9M cash.

What are the risks of investing in NEOG?

Claude: Negative operating income and inability to cover interest expense (interest coverage -0.6x) indicates unsustainable debt service. Zero revenue growth with stagnant business and minimal profitability ($3.4M net income on $645M revenue).

What is NEOG's revenue and growth?

NEOGEN CORP reported revenue of $645.1M.

Does NEOG pay dividends?

NEOGEN CORP does not currently pay dividends.

Where can I find NEOG SEC filings?

Official SEC filings for NEOGEN CORP (CIK: 0000711377) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is NEOG's EPS?

NEOGEN CORP has a diluted EPS of $0.02.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is NEOG a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, NEOGEN CORP has a SELL rating with 87% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is NEOG stock overvalued or undervalued?

Valuation metrics for NEOG: ROE of 0.2% (sector avg: 15%), net margin of 0.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy NEOG stock in 2026?

Our dual AI analysis gives NEOGEN CORP a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is NEOG's free cash flow?

NEOGEN CORP's operating cash flow is $53.0M, with capital expenditures of $47.3M. FCF margin is 0.9%.

How does NEOG compare to other Default stocks?

Vs Default sector averages: Net margin 0.5% (avg: 12%), ROE 0.2% (avg: 15%), current ratio 3.92 (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 13, 2026 | Data as of: 2026-02-28 | Powered by Claude AI